RGT Argent Biopharma Limited

 
TIDMRGT 
 
Immediate Release 
                                                            30 June 2010 
 
 
ReGen Therapeutics Plc 
("ReGen" or the "Company") 
Total Voting Rights 
 
For  the  purposes  of  the  Disclosure  and Transparency Rules of the Financial 
Services  Authority, the Board of ReGen is  required to notify the market of the 
following: 
 
As at the date of this announcement, the Company's issued share capital consists 
of  66,613,215 ordinary shares with a nominal  value of 0.01 p each, with voting 
rights  ("Ordinary Shares").  The Company  does not  hold any Ordinary Shares in 
Treasury. 
 
Therefore  the total number of Ordinary Shares in the Company with voting rights 
is 66,613,215. 
 
The  above figure of  66,613,215 Ordinary Shares may  be used by shareholders in 
the Company as the denominator for the calculations by which they will determine 
if  they are required to notify their interest in, or a change to their interest 
in,  the share  capital of  the Company  under the Financial Service Authority's 
Disclosure and Transparency Rules. 
 
 
ENDS 
 
For further information: 
 
Percy Lomax 
ReGen Therapeutics Plc 
Tel: 020 7153 4920 
 
Roland Cornish/Felicity Geidt 
Beaumont Cornish Limited 
Tel: 020 7628 3396 
 
 
 
 
 
 
 
 
 
 
[HUG#1428588] 
 
 
 
 
 
 
 
 
This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. 
The owner of this announcement warrants that: 
(i) the releases contained herein are protected by copyright and other applicable laws; and 
(ii) they are solely responsible for the content, accuracy and originality of the information contained therein. 
All reproduction for further distribution is prohibited. 
 
Source: ReGen Therapeutics Plc via Thomson Reuters ONE 
 

Argent Biopharma (LSE:RGT)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024

Argent Biopharma (LSE:RGT)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024